Downmodulation of Bcl‐2 sensitizes metastatic LNCaP‐LN3 cells to undergo apoptosis via the intrinsic pathway
- 24 November 2009
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 70 (6) , 571-583
Abstract
BACKGROUND: We explored the mechanisms of apoptosis after Bcl‐2 protein downmodulation in metastatic LNCaP‐LN3 cells (LN3).METHODS: LNCaP, LNCaP‐Pro5 (Pro5) and LN3 cells were cultured in 5% charcoal‐stripped serum (CSS) or in R1881 (synthetic androgen) and bicalutamide (synthetic anti‐androgen) and growth inhibition was assessed. Expression levels of androgen receptor (AR) and Bcl‐2 were determined. LN3 cells were transfected with small interfering RNA Bcl‐2 (siRNA Bcl‐2) or control siRNA oligonucleotides. Rates of apoptosis and proliferation were obtained. Cytochrome c localization in treated and control cells was assessed ± cyclosporine A (CsA). Caspases 9, 3, and poly (ADP‐ribose) polymerase cleavage (PARP) were measured upon downmodulation of Bcl‐2; and cell growth inhibition in vitro after Bcl‐2 modulation combined with docetaxel chemotherapy was determined.RESULTS: LN3 cells maintained growth under castrate conditions in vitro. AR protein amplification did not explain castrate‐resistant LN3 cell growth. Bcl‐2 protein levels in LN3 cells were significantly higher than in Pro5 cells, and were effectively downmodulated by siRNA Bcl‐2. Subsequently increased apoptosis and decreased proliferation mediated by cytochrome c was noted and this was reversed by CsA. siRNA Bcl‐2‐transfected LN3 cells exhibited elevated levels of caspases 9, 3, and PARP cleavage. Exposure of LN3 cells to docetaxel led to increased apoptosis, and simultaneous downmodulation of Bcl‐2 substantially enhanced this effect.CONCLUSIONS: Downmodulation of Bcl‐2 in metastatic castrate‐resistant LNCaP‐LN3 cells led to apoptosis via a cytochrome c‐dependent pathway that was enhanced with docetaxel treatment. Prostate 70: 571–583, 2010.Keywords
Funding Information
- National Cancer Institute (CA-16672)
This publication has 43 references indexed in Scilit:
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate CancerScience, 2009
- Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung CancerCancer Research, 2008
- Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy?Cell Death & Differentiation, 2008
- Control of Cyclosporine A-Induced Tumor Progression Using 15-Deoxyspergualin for Rat Cardiac TransplantationTransplantation, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate CancerClinical Cancer Research, 2005
- A Phase II, Pharmacokinetic, and Biological Correlative Study of Oblimersen Sodium and Docetaxel in Patients with Hormone-Refractory Prostate CancerClinical Cancer Research, 2005
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Superoxide anions mediate veratridine‐induced cytochrome c release and caspase activity in bovine chromaffin cellsBritish Journal of Pharmacology, 2002
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997